| AMGN | Amgen Inc | 15.14% |
| GILD | Gilead Sciences Inc | 12.75% |
| VRTX | Vertex Pharmaceuticals Inc | 9.13% |
| REGN | Regeneron Pharmaceuticals Inc | 6.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 5.41% |
| NTRA | Natera Inc | 4.92% |
| ARGX | argenx SE ADR | 4.88% |
| IQV | IQVIA Holdings Inc | 4.29% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.73% |
| BIIB | Biogen Inc | 3.63% |
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
VanEck Biotech ETF · Issued by VanEck
No recent news for BBH. The ingest cron pulls every 15 minutes during market hours.